Halloween has come and gone in the US, and Americans are now gearing up for Thanksgiving and Christmas. But before the holiday season could get underway, the country went through a major political event with far-reaching implications: the midterm elections.As…
Nichi-Iko Pharmaceutical will transfer its authorized generic (AG) versions of three brands to a Meiji Group company, including one for Allegra (fexofenadine) — Japan’s first AG, approved in 2012 and launched the following year. Nichi-Iko, Sanofi, and Meiji Seika Pharma…
To read the full story
Related Article
- Sanofi, Nichi-Iko to Dissolve Joint Venture at Year-End
October 26, 2021
BUSINESS
- Tanabe to Wind Down NeuroDerm, Scrap EU Launch of Parkinson’s Drug
November 19, 2026
- Shionogi Narrows R&D Pipeline to 21 Priority Programs Across 3 Disease Areas
November 19, 2026
- Toho, SDF Hospital Conduct Emergency Drug Supply Drill
November 19, 2026
- Japan Clears Fujirebio’s Blood-Based Aβ42 Test for Alzheimer’s
November 19, 2026
- Sobi Japan to Take Over Orfadin from Astellas in December
November 19, 2026





